M.sub.2 receptor ligand for the treatment of neurological disorders |
| Muscarinic M.sub.2 receptor ligands are described which are suitable for the treatment of ... |
|
Chemical compounds |
| We claim: 1. A compound of the formula ##STR60## wherein p is 1 or 2; R.sup.1 is hydroxy or NR.sup.2... |
|
Azolyl substituted aralkyl compounds and pesticidal use thereof |
| I claim: 1. A compound of formula (I): ##STR15## wherein R.sup.1 is hydrogen or halogen, R.sup.2 is ... |
|
3-Substituted thio-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid s-oxides |
| OF THE INVENTION The compounds of the present invention (I, above) are conveniently prepared by ... |
|
Heterobicyclic keto- and amino-acids, esters and amides |
| OF THE INVENTION The compounds of the invention may be prepared by a number of different routes ... |
|
Alkoxy anilides and pharmaceutical compositions |
| What we claim is: 1. A compound of the formula ##SPC12## wherein: m is O or an integer of 1 to 5; q ... |
|
1-Oxacephems |
| I claim: 1. The compound of the formula: ##STR59## wherein R.sup.7 is selected from the group ... |
|
6-Loweralkoxy or loweralkylthio-3-cephem-4-carboxylic acids |
| What is claimed is: 1. The compound having the following formula: ##STR7## wherein X is oxygen or ... |
|
|
Stabilized enzymatic dentifrice containing B-D-glucose and glucose oxidase
| Details |
Inventors: Pellico, Michael A.; Montgomery, Robert E.;
Assignee: Laclede Professional Products, Inc. (Gardena, CA)
Primary Examiner:
Assistant Examiner:
Attorney, Agent or Firm:
An enzymatic dentifrice is provided which contains an enzyme system comprising Beta-D-glucose and glucose oxidase for producing hydrogen peroxide upon oral application of the dentifrice. The enzymatic dentifrice is stabilized against the production of hydrogen peroxide prior to oral application of the dentifrice by limiting any water in the dentifrice to an amount not more than about 10 wt. % based on the weight of the dentifrice. |
|
DETAILED DESCRIPTION The enzymatic dentifrice of this invention comprises an enzyme system containing an oxidizable substrate, Beta-D-glucose, and an oxidoreductase enzyme specific to such substrate, glucose oxidase, for producing hydrogen peroxide upon oral application of the dentifrice, with the chemical environment of the oral cavity providing the source of the additional reactants (oxygen, water) to effect the enzymatic reaction. Glucose oxidase is characterized in the literature as a glycoprotein containing two molecules of flavine-adenine dinucleotide which has a molecular weight of approximately 150,000, an isoelectric point at pH 4. 2 and an optimum pH at 5. 5 with a broad pH range from 4 through 7. Glucose oxidase is generally present in the enzymatic dentifrice in an amount from about 0. 5 to about 500 International Units (hereinafter sometimes abbreviated as IU) per gram of dentifrice, with an intermediate range being from about 1. 0 to about 100 IU per gram of dentifrice, and a preferred range being from about 5. 0 to about 50 IU per gram of dentifrice. The term International Unit(s) identifies that amount of enzyme that will effect catalysis of 1. 0 micromole of substrate per minute at pH 7. 0 and 25. degree. C. Glucose oxidase is supplied in dry or liquid form with the label specifying the concentration in International Units on a per gram or per milliliter basis, as appropriate. D-Glucose exists in two modifications, Alpha and Beta. Ordinary glucose is primarily Alpha-D-glucose. Beta-D-glucose containing a minor amount of Alpha-D-glucose is available from specialty suppliers. Since glucose oxidase is specific to Beta-D-glucose for effecting the enzymatic reaction that produces hydrogen peroxide, it is, therefore, significantly advantageous to use a glucose composition that is predominantly the Beta form in order to minimize the amount of glucose which is added to the dentifrice and maximize the efficiency of the enzymatic reaction. Beta-D-Glucose is generally present in the enzymatic dentifrice in an amount from about 0
|
| Related patents |
|
|
Method and composition for prevention of plaque formation and plaque dependent diseases
I claim: 1. A method for preventing periodontitis in the oral cavity, said method comprising the steps of applying within the oral cavity, for a period of ten seconds, a ...
|
|
|
6-Aminopenicillanic acid sulfoxide silyl esters
I claim: 1. 6-aminopenicillanic acid sulfoxide silyl esters of the formula ##STR4## wherein R is selected from the group consisting of benzyl, phenyl (amino-methylene), ...
|
|
|
Cephalosporin esters
What I claim is: 1. A compound having the formula: ##STR12## , wherein A is phenylacetamido, phenoxyacetamido, formylamino, phthalimido, 2,2-dimethyl-3-nitroso-;b 4-...
|
|
|
Process for the preparation of unsymmetrically 1,3-disubstituted nitroso ureas
What I claim is: 1. A compound of the formula: R--NH CO N (NO) CH.sub.2 --CH.sub.2 --Cl wherein (1) R is an alkyl group of from two to six carbon atoms, which may be ...
|
|
|
Pesticidal N-[2,2-dimethyl-2,3-dihydro-7-benzofuranyl-methyl-carbamate]N-[4-] sulfide
What is claimed is: 1. N-[2,2-Dimethyl-2,3-dihydro-7-benzofuranyl methylcarbamate] N-[4-nonylphenylmethylcarbamate] sulfide. 2. An insecticidal, and nematocidal ...
|
|
|
(2-Oxo-pyrrolidines)-acetic hydrazides
What is claimed is: 1. (2-oxo-pyrrolidine-1) acetic hydrazide of the formula ##STR6## 2. A pharmaceutical preparation useful as a psychopharmacon and for treatment of ...
|
|
|
Formaldehyde stabilized coating compositions
We claim: 1. In a coating composition which comprises a film-forming material, carrier, and a 3-isothiazolone, the improvement wherein the composition further comprises ...
|
|
|
Phenoxyalkanol as a stabilizer for isothiazolone concentrates
OF THE INVENTION AND THE PREFERRED EMBODIMENTS The 3-isothiazolones of interest include those disclosed in U.S. Pat. Nos. 3,523,121 and 3,761,488 as represented by the ...
|
|
|
Nitrogen-based stabilizers for 3-isothiazolones
I claim: 1. A method of protecting against chemical degradation an isothiazolone of the formula: ##STR4## wherein Y is (C.sub.1 -C.sub.18)alkyl or (C.sub.3 -C.sub.12)...
|
|
|
Synergistic preservative systems for chemistry reagents
OF THE INVENTION In determining the antimicrobial system to use for critical care products, numerous factors had to be considered. Although there are many microbicides ...
|
|
|